Viewing Study NCT04639466


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-28 @ 8:26 PM
Study NCT ID: NCT04639466
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2020-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection
Sponsor: GeoVax, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-19
Start Date Type: ACTUAL
Primary Completion Date: 2025-10-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-02-28
Completion Date Type: ESTIMATED
First Submit Date: 2020-11-04
First Submit QC Date: None
Study First Post Date: 2020-11-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-30
Last Update Post Date: 2025-10-02
Last Update Post Date Type: ESTIMATED